Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RANKL/OPG Ratio in SLE Patients
NCT02799173Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Apr 2011
- Primary completion
- Jul 2015
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Amiens-Picardie. Primary endpoints: RANKL/Osteoprotegerin ratio at Day 0 and Presence of osteoporosis at Day 0. Started Apr 2011; status: completed.
Beyond the preview
Go deeper on NCT02799173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02799173.